An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021894
Company: BAUSCH

Medication Guide

Summary Review

Products on NDA 021894

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
XENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	AB	Yes	No
XENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021894

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/15/2008	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021894lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021894s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021894s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021894s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/13/2017	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021894Orig1s013ltr.pdf
08/25/2015	SUPPL-12	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021894Orig1s012ltr.pdf
06/03/2015	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021894s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021894Orig1s010ltr.pdf
08/02/2013	SUPPL-9	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021894Orig1s009ltr.pdf
08/17/2012	SUPPL-7	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021894Orig1s007ltr.pdf
05/04/2011	SUPPL-5	Labeling-Medication Guide, REMS-Proposal	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021894s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021894s005ltr.pdf
07/06/2011	SUPPL-4	Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021894s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021894s004ltr.pdf
12/01/2009	SUPPL-2	Labeling, REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021894s001s002ltr.pdf
12/01/2009	SUPPL-1	Labeling, REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021894s001s002ltr.pdf

Labels for NDA 021894

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/13/2017	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf
06/03/2015	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021894s010lbl.pdf
07/06/2011	SUPPL-4	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021894s004lbl.pdf
05/04/2011	SUPPL-5	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021894s005lbl.pdf
05/04/2011	SUPPL-5	REMS-Proposal	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021894s005lbl.pdf
08/15/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021894lbl.pdf

Therapeutic Equivalents for NDA 021894

XENAZINE

TABLET;ORAL; 12.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	206093	APOTEX
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	208826	BIONPHARMA
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	210544	CHARTWELL RX
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	209284	DR REDDYS
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	204574	HETERO LABS LTD V
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	207682	MYLAN
TETRABENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	No	AB	213316	SLATE RUN PHARMA
XENAZINE	TETRABENAZINE	12.5MG	TABLET;ORAL	Prescription	Yes	AB	021894	BAUSCH

TABLET;ORAL; 25MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	206686	ACTAVIS LABS FL INC
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	206093	APOTEX
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	208826	BIONPHARMA
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	210544	CHARTWELL RX
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	209284	DR REDDYS
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	204574	HETERO LABS LTD V
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	207682	MYLAN
TETRABENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	No	AB	213316	SLATE RUN PHARMA
XENAZINE	TETRABENAZINE	25MG	TABLET;ORAL	Prescription	Yes	AB	021894	BAUSCH

Top